Deyan Wu

1.3k total citations
38 papers, 1.0k citations indexed

About

Deyan Wu is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Deyan Wu has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Organic Chemistry and 10 papers in Pharmacology. Recurrent topics in Deyan Wu's work include Phosphodiesterase function and regulation (14 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Synthesis and Catalytic Reactions (6 papers). Deyan Wu is often cited by papers focused on Phosphodiesterase function and regulation (14 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Synthesis and Catalytic Reactions (6 papers). Deyan Wu collaborates with scholars based in China, United States and Netherlands. Deyan Wu's co-authors include Hai‐Bin Luo, Zhe Li, Yinuo Wu, Yi‐You Huang, Jian Li, Chen Zhang, Jin Zhu, Xiangmin Li, Hao Li and Sinan Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Deyan Wu

37 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deyan Wu China 18 513 389 209 185 94 38 1.0k
Torsten Herbertz United States 15 446 0.9× 386 1.0× 208 1.0× 105 0.6× 82 0.9× 28 1.1k
Noeris K. Salam Australia 15 724 1.4× 300 0.8× 321 1.5× 167 0.9× 80 0.9× 19 1.2k
Suman Sirimulla United States 16 495 1.0× 206 0.5× 251 1.2× 66 0.4× 52 0.6× 23 1.1k
Zhengdan Zhu China 17 268 0.5× 266 0.7× 135 0.6× 133 0.7× 86 0.9× 34 845
Sebastián A. Andújar Argentina 19 410 0.8× 314 0.8× 192 0.9× 149 0.8× 23 0.2× 42 816
M. Elizabeth Sobhia India 20 615 1.2× 369 0.9× 298 1.4× 181 1.0× 61 0.6× 94 1.2k
Danfeng Shi China 21 761 1.5× 185 0.5× 220 1.1× 119 0.6× 51 0.5× 51 1.2k
Mingyun Shen China 14 687 1.3× 166 0.4× 299 1.4× 90 0.5× 71 0.8× 15 1.0k
Bradley D. Tait United States 16 480 0.9× 788 2.0× 101 0.5× 116 0.6× 86 0.9× 27 1.5k
Federica Moraca Italy 21 735 1.4× 145 0.4× 122 0.6× 125 0.7× 83 0.9× 49 1.1k

Countries citing papers authored by Deyan Wu

Since Specialization
Citations

This map shows the geographic impact of Deyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deyan Wu more than expected).

Fields of papers citing papers by Deyan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deyan Wu. The network helps show where Deyan Wu may publish in the future.

Co-authorship network of co-authors of Deyan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Deyan Wu. A scholar is included among the top collaborators of Deyan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deyan Wu. Deyan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Furong, Tiansheng Zheng, Xue Wang, et al.. (2025). Structure-Based Optimization of Moracin M as Potent and Selective PDE4 Inhibitors with Antipsoriasis Effects. Journal of Medicinal Chemistry. 68(6). 6789–6803. 4 indexed citations
2.
3.
Wang, Sen, Kai Zhang, Tiansheng Zheng, et al.. (2024). Structural optimization of Moracin M as novel selective phosphodiesterase 4 inhibitors for the treatment of idiopathic pulmonary fibrosis. Bioorganic Chemistry. 149. 107474–107474. 3 indexed citations
4.
5.
Yao, Ziqing, Mingna Sun, Yi‐You Huang, et al.. (2023). Inhibition of AKR1Cs by liquiritigenin and the structural basis. Chemico-Biological Interactions. 385. 110654–110654. 1 indexed citations
6.
Wu, Deyan, Xuehua Zheng, Runduo Liu, et al.. (2021). Free energy perturbation (FEP)-guided scaffold hopping. Acta Pharmaceutica Sinica B. 12(3). 1351–1362. 20 indexed citations
7.
Xie, Guoyou, Yu‐Yi Ling, Deyan Wu, et al.. (2021). A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities. Acta Pharmaceutica Sinica B. 12(2). 853–866. 70 indexed citations
8.
Li, Zhe, Xin Li, Yi-You Huang, et al.. (2020). Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. Proceedings of the National Academy of Sciences. 117(44). 27381–27387. 177 indexed citations
9.
10.
Feng, Senling, Deyan Wu, De-Chong Zheng, et al.. (2019). Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents. Acta Pharmaceutica Sinica B. 10(2). 327–343. 48 indexed citations
11.
Wu, Deyan, et al.. (2018). Transition-Metal-Free C–H Arylation of Unactivated Arenes with 8-Hydroxyquinoline as a Promoter. Synthesis. 50(8). 1721–1727. 3 indexed citations
12.
Li, Jinxuan, Jingyi Chen, Qian Zhou, et al.. (2018). Structure-Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel PDE10 Inhibitors With Antioxidant Activities. Frontiers in Chemistry. 6. 167–167. 9 indexed citations
13.
Zheng, Xuehua, Siyuan Zhou, Chen Zhang, et al.. (2017). Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors. Journal of Molecular Modeling. 23(9). 272–272. 13 indexed citations
14.
Qiu, Xiaoxia, Yi‐You Huang, Deyan Wu, et al.. (2017). Discovery of novel purine nucleoside derivatives as phosphodiesterase 2 (PDE2) inhibitors: Structure-based virtual screening, optimization and biological evaluation. Bioorganic & Medicinal Chemistry. 26(1). 119–133. 11 indexed citations
15.
Huang, Yi‐You, Xin Liu, Deyan Wu, et al.. (2017). The discovery, complex crystal structure, and recognition mechanism of a novel natural PDE4 inhibitor from Selaginella pulvinata. Biochemical Pharmacology. 130. 51–59. 41 indexed citations
16.
Wu, Deyan, Jin Zhu, Chunquan Sheng, Wei Wang, & Jian Li. (2014). Synthesis of γ‐Oxo‐α,β‐dehydro‐α‐amino Acids from N–tert‐Butyloxycarbonyl‐α‐Imino Esters and Carbonylmethyl 2‐Pyridinylsulfones via an Mannich‐Elimination Cascade. Asian Journal of Organic Chemistry. 3(7). 766–768. 2 indexed citations
17.
Zhu, Jin, Deyan Wu, Xiangmin Li, et al.. (2013). A Strategy Enabling Enantioselective Direct Conjugate Addition of Inert Aryl Methane Nucleophiles to Enals with a Chiral Amine Catalyst under Mild Conditions. Chemistry - A European Journal. 19(28). 9147–9150. 74 indexed citations
18.
Wu, Deyan, Fangfang Jin, Weiqiang Lü, et al.. (2012). Synthesis, Structure–Activity Relationship, and Pharmacophore Modeling Studies of Pyrazole‐3‐Carbohydrazone Derivatives as Dipeptidyl Peptidase IV Inhibitors. Chemical Biology & Drug Design. 79(6). 897–906. 25 indexed citations
19.
Liu, Lu, Deyan Wu, Xiangmin Li, et al.. (2011). Organocatalytic enantioselective conjugate addition of ketones to isatylidine malononitriles. Chemical Communications. 48(11). 1692–1694. 47 indexed citations
20.
Kong, Yuanyuan, Deyan Wu, Hua Bai, et al.. (2007). Enzymatic Characterization and Inhibitor Discovery of a New Cystathionine  -Synthase from Helicobacter pylori. The Journal of Biochemistry. 143(1). 59–68. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Torsten Herbertz Breakdown of academic impact, for papers by Noeris K. Salam Breakdown of academic impact, for papers by Suman Sirimulla Breakdown of academic impact, for papers by Zhengdan Zhu Breakdown of academic impact, for papers by Sebastián A. Andújar Breakdown of academic impact, for papers by M. Elizabeth Sobhia Breakdown of academic impact, for papers by Danfeng Shi Breakdown of academic impact, for papers by Mingyun Shen Breakdown of academic impact, for papers by Bradley D. Tait Breakdown of academic impact, for papers by Federica Moraca
Rankless by CCL
2026